<DOC>
	<DOCNO>NCT00703404</DOCNO>
	<brief_summary>This study evaluate effectiveness first-line HIV treatment ( fixed-dose combination generic antiretroviral drug nevirapine , stavudine lamivudine ) provide Malian National HIV Treatment Program . Antiretroviral therapy become priority proven effectiveness decrease sickness death HIV infection . Reliable information efficacy need . Patients 18 year age old enter Malian National HIV Treatment Program prior antiretroviral treatment may eligible study . Primary Objective The primary objective measure virologic treatment response 24 week Malian-approved fixed-dose regimen ( FDC ) nevirapine , stavudine lamivudine ( Triomune ) patient na ( SqrRoot ) antiretroviral therapy Bamako , Mali compare historical cohort prelude clinical research investigation Mali . Secondary Objectives 1 . To assess association 24 week response response one year measure suppression viremia le 50 copies/mL 2 . To evaluate baseline clinical HIV-associated characteristic cohort person enrol protocol-mandated monitoring . Participants undergo treatment government-sponsored program . Clinical visit schedule study day 0 ( antiviral therapy start day ) 14 , 1 , 3 , 6 , 9 12 month . Patients undergo medical history , include confirm probably diagnosis make since previous visit current status , physical examination blood test CD4 viral load visit . Study start date : July 2008</brief_summary>
	<brief_title>Response Standard HIV Treatment Bamako , Mali</brief_title>
	<detailed_description>This study ass efficacy HIV treatment provide accordance Malian National HIV Treatment Program . The Malian National HIV Treatment Program use fixe dose coninaison ( FDC ) therapy , study use historical comparison African country generic antiretoviral use . Virologic response patient enrol Malian national program determine , non-inferiority design , compare historical control . The study also establish feasibility frequent HIV virologic monitoring set . Viral RNA CD4 T-cell count monitoring perform HIV-infected person see study site . All clinical decision-making prescription occur outside protocol . Decisions whether antiretroviral therapy appropriate , prescription antiretroviral therapy , monitor treatment do Malian health-care provider outside scope protocol . Viral RNA monitoring use assess endpoint viral RNA suppression limit detection ( 50 copies/mL ) .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>INCLUSION CRITERIA : HIVinfected adult ( age great equal 18 year ) naive treatment antiretroviral medication , begin regimen governmentsponsored antiretroviral treatment program alternate regimen case HIV1 HIV2 coinfected individual . The sole exception naive history use peripartum singledose nevirapine . Hemoglobin great equal 8 g/dL Ability willingness provide inform consent ability comply study requirement visit schedule . Must willing allow store sample use future study HIV disease immune function . EXCLUSION CRITERIA : Serologic evidence HIV2 infection monoinfection . Tuberculosis form patient currently undergo treatment require recommend regimen contain rifamycin antibiotic . Baseline medical condition preclude use Malian fixeddose regimen , peripheral neuropathy etiology pancreatic disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 24, 2016</verification_date>
	<keyword>Anti-Retroviral Therapy</keyword>
	<keyword>HIV</keyword>
	<keyword>Virologic Response</keyword>
	<keyword>Treatment Na√Øve</keyword>
</DOC>